246 related articles for article (PubMed ID: 22995334)
1. Expression of the vitamin D-activating enzyme 1α-hydroxylase (CYP27B1) decreases during melanoma progression.
Brożyna AA; Jóźwicki W; Janjetovic Z; Slominski AT
Hum Pathol; 2013 Mar; 44(3):374-87. PubMed ID: 22995334
[TBL] [Abstract][Full Text] [Related]
2. Expression of vitamin D receptor decreases during progression of pigmented skin lesions.
Brożyna AA; Jozwicki W; Janjetovic Z; Slominski AT
Hum Pathol; 2011 May; 42(5):618-31. PubMed ID: 21292298
[TBL] [Abstract][Full Text] [Related]
3. CYP24A1 expression inversely correlates with melanoma progression: clinic-pathological studies.
Brożyna AA; Jochymski C; Janjetovic Z; Jóźwicki W; Tuckey RC; Slominski AT
Int J Mol Sci; 2014 Oct; 15(10):19000-17. PubMed ID: 25334067
[TBL] [Abstract][Full Text] [Related]
4. On the relationship between VDR, RORα and RORγ receptors expression and HIF1-α levels in human melanomas.
Brożyna AA; Jóźwicki W; Jetten AM; Slominski AT
Exp Dermatol; 2019 Sep; 28(9):1036-1043. PubMed ID: 31287590
[TBL] [Abstract][Full Text] [Related]
5. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions.
Miracco C; Cevenini G; Franchi A; Luzi P; Cosci E; Mourmouras V; Monciatti I; Mannucci S; Biagioli M; Toscano M; Moretti D; Lio R; Massi D
Hum Pathol; 2010 Apr; 41(4):503-12. PubMed ID: 20004946
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptors (VDR), hydroxylases CYP27B1 and CYP24A1 and retinoid-related orphan receptors (ROR) level in human uveal tract and ocular melanoma with different melanization levels.
Markiewicz A; Brożyna AA; Podgórska E; Elas M; Urbańska K; Jetten AM; Slominski AT; Jóźwicki W; Orłowska-Heitzman J; Dyduch G; Romanowska-Dixon B
Sci Rep; 2019 Jun; 9(1):9142. PubMed ID: 31235702
[TBL] [Abstract][Full Text] [Related]
7. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
[TBL] [Abstract][Full Text] [Related]
8. The vitamin D receptor: a tumor suppressor in skin.
Bikle DD
Adv Exp Med Biol; 2014; 810():282-302. PubMed ID: 25207372
[TBL] [Abstract][Full Text] [Related]
9. Tumoral Vitamin D Synthesis by CYP27B1 1-α-Hydroxylase Delays Mammary Tumor Progression in the PyMT-MMTV Mouse Model and Its Action Involves NF-κB Modulation.
Li J; Luco AL; Ochietti B; Fadhil I; Camirand A; Reinhardt TA; St-Arnaud R; Muller W; Kremer R
Endocrinology; 2016 Jun; 157(6):2204-16. PubMed ID: 27119753
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of CYP27B1 correlates with the increased aggressiveness of ovarian carcinomas.
Brożyna AA; Jóźwicki W; Jochymski C; Slominski AT
Oncol Rep; 2015 Feb; 33(2):599-606. PubMed ID: 25501638
[TBL] [Abstract][Full Text] [Related]
11. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
[TBL] [Abstract][Full Text] [Related]
12. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
13. Clonal differences in expression of 25-hydroxyvitamin D(3)-1alpha-hydroxylase, of 25-hydroxyvitamin D(3)-24-hydroxylase, and of the vitamin D receptor in human colon carcinoma cells: effects of epidermal growth factor and 1alpha,25-dihydroxyvitamin D(3).
Bareis P; Kállay E; Bischof MG; Bises G; Hofer H; Pötzi C; Manhardt T; Bland R; Cross HS
Exp Cell Res; 2002 Jun; 276(2):320-7. PubMed ID: 12027461
[TBL] [Abstract][Full Text] [Related]
14. Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro.
Seifert M; Tilgen W; Reichrath J
Anticancer Res; 2009 Sep; 29(9):3659-67. PubMed ID: 19667162
[TBL] [Abstract][Full Text] [Related]
15. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
16. No association of vitamin D metabolism-related polymorphisms and melanoma risk as well as melanoma prognosis: a case-control study.
Schäfer A; Emmert S; Kruppa J; Schubert S; Tzvetkov M; Mössner R; Reich K; Berking C; Volkenandt M; Pföhler C; Schön MP; Vogt T; König IR; Reichrath J
Arch Dermatol Res; 2012 Jul; 304(5):353-61. PubMed ID: 22576141
[TBL] [Abstract][Full Text] [Related]
17. On the role of classical and novel forms of vitamin D in melanoma progression and management.
Slominski AT; Brożyna AA; Skobowiat C; Zmijewski MA; Kim TK; Janjetovic Z; Oak AS; Jozwicki W; Jetten AM; Mason RS; Elmets C; Li W; Hoffman RM; Tuckey RC
J Steroid Biochem Mol Biol; 2018 Mar; 177():159-170. PubMed ID: 28676457
[TBL] [Abstract][Full Text] [Related]
18. Patterns of melastatin mRNA expression in melanocytic tumors.
Deeds J; Cronin F; Duncan LM
Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
[TBL] [Abstract][Full Text] [Related]
19. Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1.
Rhieu SY; Annalora AJ; LaPorta E; Welsh J; Itoh T; Yamamoto K; Sakaki T; Chen TC; Uskokovic MR; Reddy GS
J Cell Biochem; 2014 Aug; 115(8):1392-402. PubMed ID: 24535953
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative Activity of Non-Calcemic Vitamin D Analogs on Human Melanoma Lines in Relation to VDR and PDIA3 Receptors.
Wasiewicz T; Piotrowska A; Wierzbicka J; Slominski AT; Zmijewski MA
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
